author-photo

Paul J. Pockros

Scripps Health
Scripps Research Institute

280

Papers

18774

Citations

Citation Trend

Filter By

Papers (199) Sort By

Journal Conference Others

Virus reactivation in a non-cirrhotic HBV patient requiring liver transplantation after cessation of nucleoside analogue therapy:

2021 Antiviral Therapy
Show All
- Source
- Cite
- Save
Citations (0)
S0984 Long-Term Efficacy and Safety of Obeticholic Acid in Patients With Primary Biliary Cholangitis: A Demographic Subgroup Analysis of 5-Year Results From the POISE Trial

2020 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States.

2020 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (2)
Hyperlipidemia with obeticholic acid in the treatment of nonalcoholic steatohepatitis

2020
- Paul J. Pockros
- Hongfei Fang
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study

2020
Show All
- Source
- Cite
- Save
Citations (5)
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

2020 Annals of Internal Medicine
Show All
- Source
- Cite
- Save
Citations (4)
ATU-09 Obeticholic acid treatment is associated with improved collagen morphometry in patients with primary biliary cholangitis

2019 Gut
Show All
- Source
- Cite
- Save
Citations (0)
Langzeitbehandlung mit Obeticholsäure ist bei Patienten mit Primär Biliärer Cholangitis mit Verbesserungen der Kollagen-Morphometrie assoziiert

2019
Show All
- Source
- Cite
- Save
Citations (0)
Long-term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis

2019 Clinical Gastroenterology and Hepatology
Show All
- Source
- Cite
- Save
Citations (32)
OC.01.4 THREE YEARS OF OBETICHOLIC ACID (OCA) THERAPY RESULTS IN HISTOLOGICAL IMPROVEMENTS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: FURTHER ANALYSIS OF THE POISE BIOPSY SUBSTUDY

2019 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (0)